MARKET

LGND

LGND

Ligand Pharma
NASDAQ
190.22
+0.02
+0.01%
Opening 11:38 12/31 EST
OPEN
189.91
PREV CLOSE
190.20
HIGH
193.54
LOW
189.40
VOLUME
23.52K
TURNOVER
--
52 WEEK HIGH
212.49
52 WEEK LOW
93.58
MARKET CAP
3.74B
P/E (TTM)
91.54
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LGND last week (1222-1226)?
Weekly Report · 2d ago
Regencell Bioscience is the top performing pharma stock YTD
Seeking Alpha · 12/23 04:47
Weekly Report: what happened at LGND last week (1215-1219)?
Weekly Report · 12/22 09:50
Ligand Pharma Highlights Broad Disclosure of Athira Investment
TipRanks · 12/18 21:30
CFO Makes Significant Move with Ligand Pharma Stock Sale
TipRanks · 12/17 02:05
Ligand Pharmaceuticals CFO Octavio Espinoza Reports Sale of Common Shares
Reuters · 12/16 23:37
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), MiMedx Group (MDXG)
TipRanks · 12/16 14:40
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
TipRanks · 12/15 15:45
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.